September 16, 2020 10:58 AM EDTUpdated 11:49 AM
People

Ex-Al­ler­gan CMO takes the helm at Lewis Cant­ley's metas­ta­sis-fo­cused biotech start­up

Amber Tong

Al­ler­gan’s for­mer top team is mov­ing on­to new ad­ven­tures as Ab­b­Vie ex­ecs take di­rect con­trol of their shop.

Just days af­ter Brent Saun­ders

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times